ABVC Stock Catalyst: ABVC BioPharma Enters Global Licensing Deal for Vitargus

Mar 25, 2024 · 4:11pm ET

The agreement includes upfront and milestone payments totaling $33.5 million.

Max move

+89.4%

High of day $1.97

Sparker timei

4:11pm ET

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

ABVC BioPharma, Inc. and ForSeeCon Eye Corporation announced on 2024-03-26 ABVC BioPharma entered into a global licensing deal for Vitargus.

The announcement cited $33.5M, $30,000,000, $3,500,000, 5%, $60,000,000, and $187M. Share consideration (payable in the issuer's shares): 30,000,000.

ABVC BioPharma, Inc. Common Stock has a free float of 20,808,200 shares and 24,301,100 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time ABVC sparks.

Catch the next ABVC-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.